Health Care · Services-Offices & Clinics of Doctors of Medicine · Nasdaq · CIK 948320 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $3.64Day −5.21%Mkt cap $176MP/E (FY) 14.6×1Y −64.3%Off 52W high −71.4%Vol (1Y) 93.4%
Daily closing price, split-adjusted to the current basis; 3y shown of 1,355 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest14.7% of sh out |
| Days to cover8.6d |
| 13F net flow (QoQ)+1.44% |
| Top-10 13F concentration68.1% |
| Next report (est.)2026-08-05 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| P/E (FY)14.6× |
| Sales (TTM)$193.3M |
| Earnings (TTM)$5.7M |
| Net margin7.4% |
| Sales growth 3Y17.7% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+6.7% |
| 1Y−64.3% |
| 3Y−23.2% |
| 5Y−63.5% |
| Since incept. (ann.)−27.9% |
Total return through 2026-07-29 · series begins 2021-03-01. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)93.4% |
| Ann. volatility (3Y)90.7% |
| Sharpe (1Y)−0.69 |
| Sharpe (3Y)0.38 |
| Max drawdown (1Y)−78.6% |
| Max drawdown (3Y)−82.5% |
| Beta (3Y vs SPY)1.29 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| BlackRock, Inc. | 2.8M | $10M | 5.81% | −0.2% |
| VANGUARD CAPITAL MANAGEMENT LLC | 1.7M | $6M | 3.44% | new |
| ROYCE & ASSOCIATES LP | 1.2M | $4M | 2.48% | +32.1% |
| RENAISSANCE TECHNOLOGIES LLC | 1.1M | $4M | 2.31% | −25.4% |
| STATE STREET CORP | 1.1M | $4M | 2.22% | +0.2% |
| GEODE CAPITAL MANAGEMENT, LLC | 1.0M | $4M | 2.11% | +6.2% |
| FEDERATED HERMES, INC. | 1.0M | $4M | 2.11% | +4.0% |
| Prescott Group Capital Management, L.L.C. | 895,424 | $3M | 1.85% | +30.3% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-06 | −$0.20 | — | $50.2M | −1.4% |
| 2025-12-31 | 2026-03-09 | — | — | $20.3M | +201.3% |
| 2025-09-30 | 2025-11-17 | — | — | $60.2M | +13.0% |
| 2025-06-30 | 2025-08-05 | −$0.05 | — | $62.7M | +23.7% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-05 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
Telehealth Subscription Revenue 58% · Telehealth 42%
business segments · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
